Corvus Pharmaceuticals, Inc. (CRVS)
10.90
-0.03
(-0.27%)
USD |
NASDAQ |
Oct 02, 16:00
10.91
+0.01
(+0.09%)
After-Hours: 20:00
Corvus Pharmaceuticals Price : 10.90 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 11.11 | 11.11 | 10.64 | 10.90 | 1.348M |
| Oct 01, 2026 | 11.56 | 11.75 | 10.89 | 10.93 | 1.309M |
| Sep 30, 2026 | 12.00 | 12.03 | 11.50 | 11.52 | 875847.0 |
| Sep 29, 2026 | 12.36 | 12.42 | 11.72 | 11.76 | 881948.0 |
| Sep 28, 2026 | 11.66 | 12.12 | 11.25 | 11.87 | 1.210M |
| Sep 25, 2026 | 11.92 | 12.04 | 11.42 | 11.62 | 1.100M |
| Sep 24, 2026 | 12.46 | 12.48 | 11.50 | 11.80 | 1.143M |
| Sep 23, 2026 | 13.30 | 13.45 | 12.24 | 12.54 | 946677.0 |
| Sep 22, 2026 | 12.55 | 13.46 | 12.35 | 13.44 | 806628.0 |
| Sep 21, 2026 | 12.80 | 12.80 | 12.28 | 12.42 | 939789.0 |
| Sep 18, 2026 | 12.53 | 12.61 | 12.25 | 12.56 | 4.461M |
| Sep 17, 2026 | 12.55 | 12.82 | 12.42 | 12.55 | 1.535M |
| Sep 16, 2026 | 13.00 | 13.14 | 12.18 | 12.23 | 952275.0 |
| Sep 15, 2026 | 13.07 | 13.17 | 12.45 | 12.95 | 1.397M |
| Sep 14, 2026 | 12.92 | 13.30 | 12.90 | 13.11 | 1.092M |
| Sep 11, 2026 | 13.13 | 13.50 | 12.77 | 12.91 | 1.258M |
| Sep 10, 2026 | 13.06 | 13.14 | 12.82 | 12.94 | 1.095M |
| Sep 09, 2026 | 13.76 | 13.90 | 12.95 | 13.33 | 1.107M |
| Sep 08, 2026 | 14.01 | 14.32 | 13.85 | 13.93 | 1.033M |
| Sep 04, 2026 | 14.34 | 14.74 | 14.34 | 14.39 | 626950.0 |
| Sep 03, 2026 | 14.38 | 14.72 | 13.98 | 14.65 | 938430.0 |
| Sep 02, 2026 | 14.38 | 14.82 | 13.87 | 14.20 | 619857.0 |
| Sep 01, 2026 | 13.86 | 14.30 | 13.84 | 14.27 | 460169.0 |
| Aug 31, 2026 | 14.09 | 14.16 | 13.71 | 14.04 | 883147.0 |
| Aug 28, 2026 | 14.60 | 14.60 | 13.98 | 14.16 | 644535.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Savara, Inc. | 4.81 |
| Vericel Corp. | 40.15 |
| Biogen, Inc. | 219.88 |
Price Related Metrics
| Price to Book Value | 4.069 |
| Earnings Yield | -5.67% |
| Market Cap | 916.92M |